Precision toxicology shows that troxerutin alleviates ochratoxin A-induced renal lipotoxicity

Area of Science:

• Nephrology
• Toxicology
• Biochemistry

Background:

• Lipotoxicity is a primary driver of severe kidney disease with limited therapeutic options.
• Precision toxicology offers advanced methods for detecting cellular changes and identifying therapeutic molecules.
• Ochratoxin A (OTA) is a nephrotoxic agent that induces lipotoxicity in renal cells.

Purpose of the Study:

• To investigate the therapeutic effects of troxerutin on OTA-induced nephrotoxicity.
• To elucidate the molecular mechanisms underlying troxerutin's protective action against renal lipotoxicity.

Main Methods:

• Induction of nephrotic syndrome in mice using OTA.
• Administration of troxerutin to assess its impact on kidney function and systemic metabolism.
• Lipidomic analysis to quantify changes in lipid profiles.
• Transcriptomic profiling of renal tubular epithelial cells to identify molecular pathways involved.

Main Results:

• Troxerutin significantly ameliorated OTA-induced nephrotoxicity, enhanced endurance, and reduced renal inflammation.
• Lipidomic analysis revealed that troxerutin decreased levels of triglycerides, phosphatidylcholines, and phosphatidylethanolamines.
• Troxerutin alleviated the overexpression of sphingomyelinase, cystic fibrosis transmembrane conductance regulator, and chloride channel 2.
• Transcriptomic data identified key metabolic factors in aberrant lipid metabolism within renal tubular epithelial cells.

Conclusions:

• Troxerutin demonstrates significant potential in alleviating ochratoxin A-induced nephrosis and associated metabolic disorders.
• The study provides novel insights into the molecular mechanisms of toxin-induced lipotoxicity in renal tubular epithelial cells.
• Precision toxicology serves as a valuable tool for understanding and treating kidney diseases driven by lipotoxicity.